Login
$MYRG
$280.03 +$13.39 (5.02%) Live

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net of allowances of $1,250 and $934, respectively
Contract assets, net of allowances of $756 and $534, respectively
Current portion of receivable for insurance claims in excess of deductibles
Refundable income taxes
Prepaid expenses and other current assets
Total current assets
Property and equipment, net of accumulated depreciation of $443,756 and $413,962, respectively
Operating lease right-of-use assets
Goodwill
Intangible assets, net of accumulated amortization of $47,948 and $39,967, respectively
Receivable for insurance claims in excess of deductibles
Deferred income taxes
Investment in joint ventures
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt
Current portion of operating lease obligations
Current portion of finance lease obligations
Accounts payable
Contract liabilities, net
Current portion of accrued self-insurance
Accrued income taxes
Other current liabilities
Total current liabilities
Deferred income tax liabilities
Long-term debt
Accrued self-insurance
Operating lease obligations, net of current maturities
Finance lease obligations, net of current maturities
Other liabilities
Total liabilities
Shareholders’ equity:
Preferred stock—$0.01 par value per share; 4,000,000 authorized shares; none issued and outstanding at September 30, 2026 and December 31, 2025
Common stock—$0.01 par value per share; 100,000,000 authorized shares; 15,570,008 and 15,522,834 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support